Resuscitated

Resuscitec develops, produces, and markets advanced medical technology designed for emergency and intensive care settings, specifically focusing on extracorporeal cardiopulmonary resuscitation (eCPR). Its flagship offering, CARL Technology, provides an integrated solution for both in-hospital and out-of-hospital resuscitation, aiming to improve patient outcomes following cardiac arrest. The company’s technical approach involves continuous innovation and the development of precisely tailored technologies for resuscitation scenarios.

The company was founded in 2010 by Univ.-Prof. Dr. Dr. h. c. Friedhelm Beyersdorf as a spin-off from Freiburg University Hospital. Dr. Beyersdorf, formerly the Medical Director of the Clinic of Cardiovascular Surgery at The Medical Center – University of Freiburg, initiated Resuscitec based on a therapeutic vision to transform resuscitation practices. This origin provided the foundational medical expertise and academic rigor necessary for developing their specialized technology.

Resuscitec’s products serve multi-professional teams within emergency medical services and intensive care units, enabling them to deliver advanced resuscitation. The company’s long-term vision is to establish itself as a global leader in extracorporeal cardiopulmonary resuscitation, consistently bringing new and effective technologies to market that enhance the prospects of survival and recovery for cardiac arrest patients worldwide.